|
| Status |
Public on Apr 10, 2023 |
| Title |
baseline_patient.39 |
| Sample type |
RNA |
| |
|
| Source name |
skin
|
| Organism |
Homo sapiens |
| Characteristics |
visitid: 2
treatment: Ixekizumab 80mg Q2W
pasi: 15.6
patient_id: 39
time: Gene expression data at baseline.
tissue: skin
disease state: chronic plaque psoriasis
|
| Treatment protocol |
subcutaneous injections of ixekizuma 80mg Q2W
|
| Growth protocol |
not applicable
|
| Extracted molecule |
total RNA |
| Extraction protocol |
standard Affymetrix protocols
|
| Label |
biotin
|
| Label protocol |
standard Affymetrix protocols
|
| |
|
| Hybridization protocol |
standard Affymetrix protocols
|
| Scan protocol |
standard Affymetrix protocols
|
| Data processing |
Raw signal intensites were normalized using the RMA algorithm implemented with R 3.5.2 and Bioconductor oligo library.
|
| |
|
| Submission date |
Jun 15, 2021 |
| Last update date |
Apr 10, 2023 |
| Contact name |
Scott Andrew Ochsner |
| E-mail(s) |
sochsner@bcm.edu
|
| Phone |
713-798-6227
|
| Organization name |
Baylor College of Medicine
|
| Department |
Molecular and Cellular Biology
|
| Lab |
SPP: Signaling Pathways Project
|
| Street address |
One Baylor Plaza
|
| City |
Houston |
| State/province |
TX |
| ZIP/Postal code |
77030 |
| Country |
USA |
| |
|
| Platform ID |
GPL17586 |
| Series (1) |
| GSE178228 |
Ixekizumab treatment of patients with moderate-to-severe plaque psoriasis. |
|
